INARI MED INC's ticker is NARI and the CUSIP is 45332Y109. A total of 230 filers reported holding INARI MED INC in Q2 2022. The put-call ratio across all filers is 2.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,001,966 | -40.2% | 168,226 | -46.8% | 0.08% | -33.6% |
| Q2 2023 | $18,395,604 | +0.2% | 316,402 | +6.4% | 0.12% | +8.9% |
| Q1 2023 | $18,356,846 | +255.1% | 297,325 | +265.6% | 0.11% | +273.3% |
| Q4 2022 | $5,169,208 | +17.4% | 81,328 | +34.1% | 0.03% | +20.0% |
| Q3 2022 | $4,404,000 | +283.3% | 60,627 | +258.8% | 0.02% | +257.1% |
| Q2 2022 | $1,149,000 | -69.6% | 16,896 | -59.5% | 0.01% | -78.1% |
| Q1 2022 | $3,779,000 | +198.5% | 41,691 | +200.5% | 0.03% | +166.7% |
| Q4 2021 | $1,266,000 | +63.8% | 13,876 | +45.6% | 0.01% | +20.0% |
| Q3 2021 | $773,000 | -82.6% | 9,530 | -80.0% | 0.01% | -80.0% |
| Q2 2021 | $4,435,000 | +113.0% | 47,547 | +144.4% | 0.05% | +85.2% |
| Q1 2021 | $2,082,000 | -13.4% | 19,455 | -29.4% | 0.03% | -18.2% |
| Q4 2020 | $2,405,000 | +30.9% | 27,552 | +3.5% | 0.03% | +22.2% |
| Q3 2020 | $1,837,000 | – | 26,612 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darsana Capital Partners LP | 1,475,000 | $137,588,000 | 3.91% |
| Affinity Asset Advisors, LLC | 85,000 | $7,929,000 | 2.84% |
| Parian Global Management LP | 49,800 | $4,645,000 | 1.99% |
| AlpInvest Partners B.V. | 27,960 | $2,608,000 | 1.28% |
| Sio Capital Management, LLC | 46,332 | $4,322,000 | 1.07% |
| HARBOURVEST PARTNERS LLC | 88,598 | $8,264,000 | 0.79% |
| HAMILTON LANE ADVISORS LLC | 26,403 | $2,463,000 | 0.77% |
| Pier Capital, LLC | 76,708 | $7,155,000 | 0.72% |
| Lisanti Capital Growth, LLC | 46,035 | $4,294,000 | 0.53% |
| NEXT CENTURY GROWTH INVESTORS LLC | 66,822 | $6,233,000 | 0.49% |